Warfarin Sensitivity Genotype by Sequence Analysis, Blood
NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.
Identifying patients who may require warfarin dosing adjustments(2,3) including:
-Patients who have previously been prescribed warfarin and have required multiple dosing adjustments to maintain the international normalized ratio in the target range
-Patients with a history of thrombosis or bleeding when previously taking warfarin
-Patients being started on a first prescription for warfarin
Profile Information A profile is a group of laboratory tests that are ordered and performed together under a single Mayo Test ID. Profile information lists the test performed, inclusive of the test fee, when a profile is ordered and includes reporting names and individual availability.
|Test ID||Reporting Name||Available Separately||Always Performed|
|WARFS||Warfarin Sensitivity, Genotype||No||Yes|
|WARFQ||Warfarin Sensitivity Genotyping||No||Yes|
Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.
Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test
Polymerase Chain Reaction (PCR) Followed by DNA Sequence Analysis
Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name
Cytochrome P450 2C9 Genotyping
P450 2C9 Genotyping
Vitamin K Epoxide Reductase Subunit 1
Vitamin K Genotype (VKORC1)
VKORC1 and 2C9